Thermo Fisher col­lab­o­rates with Ortho Clinical Di­ag­nos­tics

BioSpectrum (Asia) - - SUPPLIER NEWS -

Ortho Clinical Di­ag­nos­tics, a global leader of in vitro di­ag­nos­tics, has an­nounced an in­ter­na­tional dis­tri­bu­tion and co-pro­mo­tion agree­ment with Thermo Fisher Sci­en­tific to pro­vide 14 as­says used to mon­i­tor ther­a­peu­tic drugs, im­muno­sup­pres­sive drugs and drugs of abuse. The agree­ment is part of Ortho’s on­go­ing Mi­croTip Part­ner­ship As­says pro­gram, through which Ortho col­lab­o­rates with other di­ag­nos­tics com­pa­nies to val­i­date and de­liver a broad range of as­says to the hos­pi­tals, hos­pi­tal net­works and labs who use Ortho’s VITROS 4600 Chem­istry Sys­tem and VITROS 5600 In­te­grated Sys­tem.

The im­muno­sup­pres­sive drugs tests cov­ered by this agree­ment are used to mon­i­tor trans­plant pa­tients to pre­vent over-sup­pres­sion or or­gan re­jec­tion, while the ther­a­peu­tic drug tests are used to con­firm drug lev­els in the body and mon­i­tor com­pli­ance and tox­i­c­ity. The test­ing menu for drugs of abuse is used to mon­i­tor both il­licit and pre­scrip­tion drugs in cases of sus­pected abuse.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.